# OXCARBAZEPINE
> **ANDA218442** · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA LTD · Approved 2025-01-08
## Drug
- **FDA Application Number:** ANDA218442
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXCARBAZEPINE
- **Generic name:** Oxcarbazepine
- **Active ingredients:** OXCARBAZEPINE
- **Dosage form:** TABLET
- **Route:** EXTENDED RELEASE
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** BIOCON PHARMA LTD
- **First approval:** 2025-01-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218442)
---
*MORVS · CC0 1.0*